Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets, in Androgenetic Alopecia in Males with a Comparator Arm
|Effective start/end date||3/1/16 → 3/30/21|
- Allergan, Inc.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.